Tumor-promoting action of obesity in ER+ breast tumors is often explained by enhanced estrogen signaling, owing to induction of aromatase expression in “obese” adipose tissue and augmented extragonadal synthesis of estrogen [30,41,42,58]. The gene discussed is ESR1; the disease is obesity due to melanocortin 4 receptor deficiency.